Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia - Wikidata - wikimedia - TriplyDB

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

http://www.wikidata.org/entity/Q34106566

about

Resistance of M. leprae to quinolones: a question of relativity?Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection.Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia.Efficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic mice Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration Animal models of Streptococcus pneumoniae disease Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis.In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae.In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.Pharmacokinetics and residue depletion of erythromycin in gilthead sea bream Sparus aurata L. after oral administration.In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.Pharmacokinetics and residue depletion of erythromycin in rainbow trout Oncorhynchus mykiss (Walbaum).

P2860

Q28535115-E5D83EA9-A861-44A7-9DC8-F2B9BE97D5D0 Q33318590-5EA1F1C5-9401-4CCC-B48C-F99463DED8DF Q33555366-A7DA6FAD-705B-4ABE-86CC-A5C78204C5DA Q34142444-EFE34AFB-1C7D-4407-9C66-785EC604F0A4 Q34938903-028A4D47-81CD-48E7-8E70-2AA6B03F0BBE Q35210467-35E9B708-6181-46A0-B6E4-BE2C0360EC52 Q35627730-9B38BA70-13D9-4C78-8C62-39A623078FE6 Q35761235-1F55053B-7BD2-40E9-8FCD-6F479C4F959D Q36022938-8EE875FA-B553-4039-9476-58B7C9E38FA0 Q36320604-95F53E7E-3505-483D-8B2A-559B8538AEC4 Q36320613-3741DC59-4392-42DC-8AF8-A74E526C254F Q36744877-E1ECA6A7-F194-4D9E-99A0-AB86A545C74F Q37247655-EBD9B28B-2085-40D3-909B-2B1A009FFCAA Q37293669-6683E96E-C996-4C8D-A17A-45275AC2E355 Q37868241-1CA95D5A-039E-473A-9BC4-2D91BE910DA2 Q39731976-A805C398-DB76-44EF-A49A-8D0D5338638A Q39769151-07AA7CC8-2E50-4CB7-AC56-67D127C89DA7 Q40410604-33B3B3D1-E6FA-4263-98CA-3BD25317FBA0 Q41887195-E4DF1BD2-FD8C-42DC-962D-A10420455246 Q42111255-36AEB012-BDF9-4561-90ED-2474E2E4C0BD Q43744039-89B682C9-E9CB-42CB-A2DC-EF8C6B356B9B Q44361727-45CCC3FD-D3F3-480A-95C1-874859E0DA6F Q46514173-B2584704-FCC2-400A-9791-2F970DA60284 Q46983972-68A1F7C4-C359-427E-A727-24BF7427C596

P2860

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

http://www.wikidata.org/entity/Q34106566

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@ast

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@en

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@nl

type

label

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@ast

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@en

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@nl

prefLabel

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@ast

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@en

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@nl

P1433

Q34106566-E9C9351B-9D02-42B0-BC82-C066A70D48D8

P1476

Q34106566-0F7AD8B8-1361-41D2-9B9F-9EFDC1CAB98C

P2093

Q34106566-03478A22-A4B5-46B3-B4E3-4A9F81271D2D

Q34106566-1F1946FB-4ADF-449F-9036-A70429B84359

Q34106566-2158DCF4-9715-4343-B453-375A1DF94AFE

Q34106566-4E2F76AD-D1A9-407C-95DB-43362ECEFCCA

Q34106566-6847845A-9104-4DBF-AFF9-AAD7CE5A27B4

Q34106566-C043F53B-FAA3-4FC5-87B5-E46C72939666

Q34106566-D1057849-320F-4658-AE40-E1EF9019EF06

Q34106566-FA3497DC-F4EC-4423-9F25-9BDC05CA5937

P2860

Q34106566-0AE0CB42-0C25-432F-BBF4-284707567EC5

Q34106566-4256DBD4-0291-4492-B026-EA61364EC71B

Q34106566-6067D55D-08FE-47EA-A26F-65EA1B91248A

Q34106566-609C1918-05F4-4ACA-A19B-AA58BBEBD949

Q34106566-7784DD19-790B-4A86-BF56-F6DC9D47C590

Q34106566-878E8F58-69CA-4D26-95EE-46FBBFAC14B6

Q34106566-8FB51EA9-5901-4E21-9326-057345252485

Q34106566-97CD59A6-960F-4048-BD46-2FBA82E78306

Q34106566-A18C9DE0-8A2A-4FAC-A440-855A796B540D

Q34106566-C2BB65C2-EA01-4F3E-93D1-25C2E3081D2C

P304

Q34106566-90D9C6F3-0980-4534-AE27-181B382C83E0

P31

Q34106566-0240ADD8-01B7-4CD0-9A51-7BBFD7AD8248

P356

Q34106566-55C8FB84-1C1A-4B81-A516-3820C5004928

P407

Q34106566-723E160C-2D8E-4246-BA93-1BB96FD89F71

P433

Q34106566-7EE5ACA3-76EA-475F-82DF-F1A20A31EC92

P478

Q34106566-60E525A1-5AAB-48A2-A876-5E2C31D6163F

P577

Q34106566-78554B35-D4FC-47E1-BE5B-8EB480087653

P5875

Q34106566-AB4536FF-4F18-4371-9533-8C2DB9E5E6EF

P698

Q34106566-F63EC9A0-DE34-41C5-B477-500419CD7B44

P921

Q34106566-7A4B2B1D-053F-4E13-9060-CB1505CF26BB

P932

Q34106566-37BEAD10-89D7-431A-BEA3-6D2093F99B0A

P356

AAC.46.5.1425-1434.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia

@en

P2093

Charles H Nightingale

http://www.w3.org/2001/XMLSchema#string

Chonghua Li

http://www.w3.org/2001/XMLSchema#string

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

Dawei Xuan

http://www.w3.org/2001/XMLSchema#string

Min Ye

http://www.w3.org/2001/XMLSchema#string

Myo-Kyoung Kim

http://www.w3.org/2001/XMLSchema#string

Pamela R Tessier

http://www.w3.org/2001/XMLSchema#string

Wen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen.

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model

Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance.

Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae

Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice

Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin

P304

1425-1434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.5.1425-1434.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11407029

http://www.w3.org/2001/XMLSchema#string

P698

11959578

http://www.w3.org/2001/XMLSchema#string

P921

P932

127127

http://www.w3.org/2001/XMLSchema#string